Markets:

Overview

News

Currencies

International

Treasuries

BridgeBio Pharma, Inc. - Common Stock (NQ:BBIO)

73.64 -1.12 (-1.50%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BridgeBio Pharma, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

21 Stocks Moving In Friday's Mid-Day Session ↗

December 31, 2021

Gainers Nutriband Inc. (NASDAQ: NTRB) shares jumped 120.2% to $8.61 after the company announced the Korean Intellectual Property Office has fully issued its patent titled "...

Via Benzinga

3 Stocks Insiders Are Buying ↗

December 31, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...

Via Benzinga

45 Biggest Movers From Yesterday ↗

December 29, 2021

Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares climbed 64.8% to close at $19.02 on Tuesday as traders circulated a social media post on a potential short squeeze. ShiftPixy...

Via Benzinga

Where BridgeBio Pharma Stands With Analysts ↗

December 28, 2021

Within the last quarter, BridgeBio Pharma (NASDAQ:BBIO) has observed the fo...

Via Benzinga

Unusual Options Activity Insight: BridgeBio Pharma ↗

August 10, 2021

BridgeBio Pharma (NASDAQ:BBIO) shares experienced unusual...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 28, 2021

Gainers BridgeBio Pharma (NASDAQ:BBIO) shares increased by 17.7% to $13.39 during Tuesday's regular session. Trading volume for this security as of 12:32 EST is 25.2...

Via Benzinga

Why BridgeBio Pharma Shares Are Rising ↗

December 28, 2021

BridgeBio Pharma Inc (NASDAQ: BBIO) is trading higher Tuesday as the stock rebounds after falling on Monday. BridgeBio Pharma shares traded lower Monday after the...

Via Benzinga

25 Stocks Moving In Tuesday's Mid-Day Session ↗

December 28, 2021

Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 64.6% to $18.99 as traders circulated a social media post on a potential short squeeze. Flotek Industries, Inc. (NYSE...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

December 28, 2021

Argus Research raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,010 to $1,313. Tesla shares rose 1.8% to $1,113.84 in pre-market trading. Needham boosted the price target...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 28, 2021

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 41.2% to $3.29 during Tuesday's pre-market session. The company's market cap stands at $47.1...

Via Benzinga

51 Biggest Movers From Yesterday ↗

December 28, 2021

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges Over 200 Points; Microbot Medical Shares Spike Higher ↗

December 27, 2021

Toward the end of trading Monday, the Dow traded up 0.64% to 36,181.37 while the NASDAQ rose 1.19% to 15,838.88. The S&P also rose, gaining 1.07% to 4,776.31. The U.S. has the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 27, 2021

Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 47.87% to $8.02 during Monday's regular session. The current volume of 63.6 million shares is 153229.83%...

Via Benzinga

S&P 500 Nabs Fresh Intraday High Amid Extended Rally ↗

December 27, 2021

Stocks are extending their post-holiday climb, with the Dow Jones Industrial Average up 200 points at midday. The S&P 500 Index also sports sizable gains, while the Nasdaq Composite is eyeing a notable...

Via Talk Markets

Mid-Day Market Update: Nasdaq Rises 1%; BridgeBio Pharma Shares Plunge ↗

December 27, 2021

Midway through trading Monday, the Dow traded up 0.54% to 36,146.21 while the NASDAQ rose 1.04% to 15,815.70. The S&P also rose, gaining 0.87% to 4,766.92. The U.S. has the...

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

December 27, 2021

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY...

Via Benzinga

Why BridgeBio Pharma Shares Are Plummeting Today ↗

December 27, 2021

BridgeBio Pharma Inc (NASDAQ: BBIO) is trading significantly lower Monday morning after the company announced that its Phase 3 trial to treat symptomatic transthyretin amyloid...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; News Corp To Buy Base Chemicals ↗

December 27, 2021

Following the market opening Monday, the Dow traded up 0.39% to 36,089.53 while the NASDAQ rose 0.78% to 15,774.78. The S&P also rose, gaining 0.70% to 4,758.97. The U.S. has...

Via Benzinga

BridgeBio Pharma Stock Crashes As Pfizer-Rivaling Heart Drug Flops ↗

December 27, 2021

Patients who received the drug didn't improve in the six-minute walking test.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 27, 2021

Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 55.35% to $8.42 during Monday's pre-market session. The company's market cap stands at $59.8 million...

Via Benzinga

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus ↗

December 26, 2021

Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key...

Via Talk Markets

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year ↗

December 26, 2021

Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating...

Via Benzinga

63 Biggest Movers From Friday ↗

December 20, 2021

Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...

Via Benzinga

How Alnylam Pharmaceuticals Could Take On Pfizer With A 'Catalyst-Rich' 2022 ↗

November 22, 2021

Alnylam is working on a drug that could tackle transthyretin cardiomyopathy.

Via Investor's Business Daily

BridgeBio Pharma Secures Debt Financing Of $750M ↗

November 18, 2021

BridgeBio Pharma Inc (NASDAQ: BBIO) has executed a definitive credit facility agreement with a syndicate of lenders for up to $750 million in financing. This facility,...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

October 04, 2021

RBC Capital boosted Tesla, Inc. (NASDAQ:TSLA) pri...

Via Benzinga

BridgeBio Pharma's Candidate For Muscle-Wasting Disorder Wins Fast Track Tag In US ↗

September 15, 2021

The FDA has granted Fast Track Designation to BridgeBio Pharma Inc's (NASDAQ: BBIO) BBP-418 as a treatment option for Limb-girdle Muscular Dystrophy Type...

Via Benzinga

BridgeBio Pharma and LianBio Announce First Patient Treated in Phase 2a Trial of Infigratinib in Patients with Gastric Cancer and Other Advanced Solid Tumors

August 25, 2021

From LianBio

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 06, 2021

Gainers Opiant Pharmaceuticals (NASDAQ:OPNT

Via Benzinga

BridgeBio Pharma Stock Sees Rising Relative Strength; Still Shy Of Key Threshold ↗

July 01, 2021

In a welcome move, biotech BridgeBio Pharma stock saw its Relative Strength Rating rise from 70 to 73 on Thursday.

Via Investor's Business Daily

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.